Search

Your search keyword '"Riva,Nicoletta"' showing total 13 results
Start Over Author "Riva,Nicoletta" Publisher georg thieme verlag kg
13 results on '"Riva,Nicoletta"'

3. Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score

Author

de Winter, Maria A., additional, Dorresteijn, Jannick A. N., additional, Ageno, Walter, additional, Ay, Cihan, additional, Beyer-Westendorf, Jan, additional, Coppens, Michiel, additional, Klok, Frederikus A., additional, Moustafa, Farès, additional, Riva, Nicoletta, additional, Ruiz Artacho, Pedro C., additional, Vanassche, Thomas, additional, and Nijkeuter, Mathilde, additional

Published
2021
Full Text
View/download PDF

7. Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE

Author

Barco, Stefano, additional, Granziera, Serena, additional, Coppens, Michiel, additional, Douxfils, Jonathan, additional, Nijkeuter, Mathilde, additional, Riva, Nicoletta, additional, Vanassche, Thomas, additional, Zhang, George, additional, Lin, Min, additional, Kamphuisen, Pieter, additional, Cohen, Alexander, additional, and Beyer-Westendorf, Jan, additional

Published
2019
Full Text
View/download PDF

11. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism

Author

Bellesini, Marta, primary, Minno, Matteo Nicola Dario Di, primary, Mumoli, Nicola, primary, Pomero, Fulvio, primary, Franchini, Massimo, primary, Fantoni, Chiara, primary, Lupoli, Roberta, primary, Brondi, Barbara, primary, Borretta, Valentina, primary, Bonfanti, Carlo, primary, Ageno, Walter, primary, Dentali, Francesco, primary, and Riva, Nicoletta, additional

Published
2014
Full Text
View/download PDF

13. Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

Author

Jan Beyer-Westendorf, Soo Mee Bang, Walter Ageno, Francesco Dentali, Nicoletta Riva, Maria Teresa Sartori, Giovanni Barillari, Sam Schulman, Matteo Nicola Dario Di Minno, Elvira Grandone, Ageno, Walter, Riva, Nicoletta, Schulman, Sam, Bang, Soo Mee, Sartori, Maria Teresa, Grandone, Elvira, Beyer Westendorf, Jan, Barillari, Giovanni, DI MINNO, Matteo, and Dentali, Francesco

Subjects
Registrie, Male, vitamin K antagonist, Vitamin K, Fibrosi, heparin, splanchnic vein thrombosis, Retrospective Studie, Risk Factors, Neoplasms, Age Factor, Registries, Splanchnic Circulation, Prospective cohort study, Aged, 80 and over, Venous Thrombosis, Fibrinolytic Agent, Anticoagulant, Age Factors, splanchnic vein thrombosi, Hematology, Middle Aged, Vitamin K antagonist, Thrombosis, Portal vein thrombosis, Venous thrombosis, Female, Gastrointestinal Hemorrhage, Cardiology and Cardiovascular Medicine, Human, Adult, Gastrointestinal bleeding, medicine.medical_specialty, Adolescent, medicine.drug_class, Follow-Up Studie, Fibrinolytic Agents, Internal medicine, medicine, Humans, Venous Thrombosi, Aged, Retrospective Studies, business.industry, Risk Factor, medicine.disease, Fibrosis, Surgery, Splanchnic vein thrombosis, Neoplasm, business, Follow-Up Studies
Abstract

Treatment of splanchnic vein thrombosis (SVT) is a clinical challenge due to heterogeneity of clinical presentations, increased bleeding risk, and lack of evidences from clinical trials. We performed an international registry to describe current treatment strategies and factors associated with therapeutic decisions in a large prospective cohort of unselected SVT patients. A total of 613 patients were enrolled (mean age 53.1 years, standard deviation ± 14.8); 62.6% males; the majority (468 patients) had portal vein thrombosis. Most common risk factors included cirrhosis (27.8%), solid cancer (22.3%), and intra-abdominal inflammation/infection (11.7%); in 27.4% of patients, SVT was idiopathic. During the acute phase, 470 (76.7%) patients received anticoagulant drugs, 136 patients (22.2%) remained untreated. Incidental diagnosis, single vein thrombosis, gastrointestinal bleeding, thrombocytopenia, cancer, and cirrhosis were significantly associated with no anticoagulant treatment. Decision to start patients on vitamin K antagonists after an initial course of parenteral anticoagulation was significantly associated with younger age, symptomatic onset, multiple veins involvement, and unprovoked thrombosis. Although a nonnegligible proportion of SVT patients did not receive anticoagulant treatment, the majority received the same therapies recommended for patients with usual sites thrombosis, with some differences driven by the site of thrombosis and the pathogenesis of the disease.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results